Clinical characteristics and impacts of traditional Chinese medicine treatment on the convalescents of COVID-19

An, Yu; Yuan, Bo; Wang, Jian-Chun; Wang, Cheng; Liu, Tingting; Song, Shuo; Liu, Hanqing

doi:10.7150/ijms.52664

Cited by 18 publications

(16 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Liver function remained the novel level in both moderate and severe groups (Shu et al, 2020). This is consistent with other cohort studies (An et al, 2021;Wang et al, 2021). The Indian traditional medical system is one of the oldest medical practice systems in the world.…”

Section: Traditional Medicinesupporting

confidence: 89%

Drug-Induced Liver Disturbance During the Treatment of COVID-19

Zhai

Wang

et al. 2021

Front. Pharmacol.

View full text Add to dashboard Cite

An outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) occurred in Wuhan, China, at the end of 2019. The World Health Organization named the resulting infectious disease as coronavirus disease-2019 (COVID-19). Many studies concluded that patients infected with SARS-CoV-2 have different degrees of liver disturbance. However, the relationship between the drugs used for COVID-19 treatment and liver disturbance remains controversial. It is essential to evaluate the potential liver damage caused by various drugs in order to help guide clinical practice. This review analyzed the effect of drugs on hepatic function during the treatment of COVID-19.

show abstract

Section: Traditional Medicinesupporting

confidence: 89%

Drug-Induced Liver Disturbance During the Treatment of COVID-19

Zhai

Wang

et al. 2021

Front. Pharmacol.

View full text Add to dashboard Cite

show abstract

“…A recent paper published in The Lancet on 6-month consequences of 1733 COVID-19 patients revealed that those with severe disease discharged from hospital showed common syndromes of fatigue or muscle weakness, sleep difficulties, and anxiety or depression 281 , 282 . Meanwhile, a comparison of 425 non-treatment with 143 TCM-treated COVID-19 patients post discharge showed that TCM was beneficial for decreasing IL-6 and procalcitonin, and increasing red blood cell, hemoglobin, and platelet count 283 .…”

Section: Discussionmentioning

confidence: 99%

Traditional Chinese medicine in COVID-19

Lyu

Fan

Xiao

et al. 2021

Acta Pharmaceutica Sinica B

134

110

View full text Add to dashboard Cite

COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread across the globe, posing an enormous threat to public health and safety. Traditional Chinese medicine (TCM), in combination with Western medicine (WM), has made important and lasting contributions in the battle against COVID-19. In this review, updated clinical effects and potential mechanisms of TCM, presented in newly recognized three distinct phases of the disease, are summarized and discussed. By integrating the available clinical and preclinical evidence, the efficacies and underlying mechanisms of TCM on COVID-19, including the highly recommended three Chinese patent medicines and three Chinese medicine formulas, are described in a panorama. We hope that this comprehensive review not only provides a reference for health care professionals and the public to recognize the significant contributions of TCM for COVID-19, but also serves as an evidence-based in-depth summary and analysis to facilitate understanding the true scientific value of TCM.

show abstract

“…Amid them, traditional Chinese medicine (TCM) has enjoyed unprecedented success. An et al indicated that traditional Chinese medicine could effectively increase the number of WBC, decreased the serum levels of IL-6 and procalcitonin, and more importantly elevated the number of PLTs in patients [148] . Inline,Chen et al treated one group of patients with Jianpi Yiqi Shexue (JYS) granules and the other group with prednisone; although prednisolone more significantly increased the number of PLTs, Jianpi Yiqi Shexue could stop bleeding more rapidly in the patients [149] .…”

Section: Thrombocytopenia-related Treatment In Covid-19mentioning

confidence: 99%